Hacker News Reader

How about ZMapp? An artificial antibody produced in a plant that is the first meaningful advancement in treating Ebola?

You could also go through the 160 other monoclonal antibodies that are in clinical trials to see if any of them are exciting.

https://en.wikipedia.org/wiki/Monoclonal_antibody

Making them and understanding how to prevent adverse reactions to them both involve genetics.

View on HN

No, not enough. I credit you that serious work is being done, but I think it is pretty clear that unless the Phase 1, 2 and most of 3 trials can be automated somehow then the idea of personalized medicine is a fiction. The approval of 16 new drugs per year isn't going to cut it. The FDA has only approved around 1500 drugs in its entire lifetime.

At that rate cures for diseases would have to be complete panaceas in order to have a measurable effect on lifespan or healthspan.

Reply on news.ycombinator.com